STABLE CRYSTALLINE FORM OF REGADENOSON

The present invention provides crystalline Form S of regadenoson which is substantially free of residual organic solvent and having an X-ray powder diffraction pattern comprising characteristic peak at 10.3, 10.8, 19.0, 21.6 and 25.5 ± 0.2 degrees 2θ. La présente invention concerne la Forme cristall...

Full description

Saved in:
Bibliographic Details
Main Authors DWIVEDI, Shriprakash Dhar, KARANKE, Sunil Rajaram, YADAV, Arunkumar Gulabsingh, PATEL, Nischalkumar Vinodbhai, THENNATI, Rajamannar
Format Patent
LanguageEnglish
French
Published 23.08.2018
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides crystalline Form S of regadenoson which is substantially free of residual organic solvent and having an X-ray powder diffraction pattern comprising characteristic peak at 10.3, 10.8, 19.0, 21.6 and 25.5 ± 0.2 degrees 2θ. La présente invention concerne la Forme cristalline S de régadénoson qui est sensiblement exempte de solvant organique résiduel et ayant un diagramme de diffraction des rayons X sur poudre comprenant un pic caractéristique à 10,3, 10,8, 19,0, 21,6 et 25,5 ± 0,2 degrés 2θ.
Bibliography:Application Number: WO2016IN50303